NCT01797536View on ClinicalTrials.gov

The Influence of Hepatic Insufficiency on the Pharmacokinetics of Elbasvir (MK-8742) (MK-8742-009)

PHASE1CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

March 6, 2013

Primary Completion Date

August 20, 2014

Study Completion Date

August 20, 2014

Conditions
Hepatic Insufficiency
Interventions
DRUG

Elbasvir

Trial Locations (2)

32809

Call for Information (Investigational Site 0001), Orlando

33136

Call for Information (Investigational Site 0003), Miami

Sponsors

Collaborators (1)

Celerion
All Listed Sponsors
collaborator

Celerion

INDUSTRY

lead

Merck Sharp & Dohme LLC

INDUSTRY